Coloplast A/S CLPBF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 249.78% | -168.47% | 58.86% | 11.93% | -4.82% |
| Total Depreciation and Amortization | 858.56% | -0.34% | 88.62% | -45.36% | 7.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -218.66% | 726.69% | -59.54% | 43.60% | 2.56% |
| Change in Net Operating Assets | 95.67% | -373.35% | -5.68% | 418.91% | 93.85% |
| Cash from Operations | 16.03% | -35.32% | -1.90% | 43.01% | 137.03% |
| Capital Expenditure | 35.98% | -6.99% | -0.58% | 0.27% | -46.35% |
| Sale of Property, Plant, and Equipment | -71.58% | 244.82% | 99.04% | 202.96% | -207.80% |
| Cash Acquisitions | 101.41% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 51.61% | -73.57% | -81.70% | 37.67% | -36.59% |
| Cash from Investing | 52.54% | -46.34% | -5.11% | 4.15% | -46.22% |
| Total Debt Issued | -64.50% | -120.41% | 109.97% | 9,758.33% | 102.30% |
| Total Debt Repaid | 165.57% | -518.84% | 97.56% | -3,997.10% | 9.21% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 100.00% | -- | 100.00% | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -78.93% | 43.96% | 0.62% | -42.99% | -113.50% |
| Foreign Exchange rate Adjustments | -37.17% | 1,971.33% | 90.05% | 66.78% | -178.58% |
| Miscellaneous Cash Flow Adjustments | -100.00% | -- | -- | -- | -- |
| Net Change in Cash | -328.78% | -132.10% | -19.86% | 7,686.85% | 98.17% |